ReviewCommunications biology2026
Mitochondria as convergence hubs for innate immunity pathways.
Review in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitochondria have emerged as a central platform for integrating innate immune signaling by actively releasing damage-associated molecular patterns (DAMPs). Under stress or infection, these mitochondria-derived molecular signals precisely regulate the activation of cGAS-STING signaling, the NLRP3 inflammasome, and mitochondrial antiviral signaling protein (MAVS)-dependent antiviral pathways, dynamically coupling cellular metabolic states with immune responses. Recent studies have revealed that mitochondria possess dual functions as bioenergetic generators and innate immune signaling hubs in host defense, inflammation regulation, and autoimmunity. Deepening our understanding of how mitochondria synergistically integrate bioenergetics, redox homeostasis, and pattern recognition mechanisms will open novel therapeutic pathways for immune diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.